|
The Carpentier-Edwards PERIMOUNT aortic valve is the first biomechanically engineered valve designed specifically for the aortic position. It combines an enduring design with the benefits of pericardial tissue.
- The PERIMOUNT aortic pericardial tissue valve delivers performance with a proven track record of uncompromised durability up to 20 years in the aortic position1
- PERIMOUNT valves are supported by 17 years of proven hemodynamic stability2
- Optimum material choice for both tissue and stent because the materials have well-defined and understood properties
- Comprehensive design of leaflet shape and stent allow for a precise fit
- Integrated processes such as Neutralogic stress-free fixation, tissue thickness measurements, and tissue deflection testing enable the leaflets to be accurately matched
- XenoLogiX tissue treatment eliminates up to 98% of phospholipids, a major calcium binding site.*
* No clinical data are available which evaluate the long-term impact of the Edwards Lifesciences tissue treatment in patients.
|
|
|
|
|